Todd Stottlemyer

Todd A. Stottlemyer currently serves as CEO of CNSI and as a member of the company’s Board of Directors. Todd is responsible for the overall health of the company and leads CNSI’s management with an emphasis on identifying new strategic markets and leveraging relationships with customers and partners.

Prior to joining CNSI, Todd served as an Executive Vice President and member of the executive leadership team for the Inova Health System, an 18,000-employee healthcare organization serving the greater Washington, DC region, and as CEO of the Inova Center for Personalized Health, where he was responsible for the Inova Schar Cancer Institute, the Inova Translational Medicine Institute, Inova’s research programs, the Inova Strategic Investment Initiative (venture fund), and the Inova Personalized Health Accelerator.

Before joining NFIB, Todd was a founder, CEO, and a member of the Board of Directors of Apogen Technologies, a private equity-backed (Arlington Capital Partners) information technology company. During Todd’s tenure as CEO of Apogen, the company’s annual revenue grew to more than $200 million. In September of 2005, Todd led the successful sale of Apogen to QinetiQ Group PLC, a publicly-traded British technology company. During Todd’s tenure, Apogen was named as one of the top 50 best places to work in the Washington, D.C. area and as one of the top 20 best places to work in the New Orleans, LA area.

Todd attended The College of William & Mary, graduating Phi Beta Kappa with a B.A, and he received a Juris Doctor degree from the Georgetown University Law Center.